Lv4
668 积分 2024-11-24 加入
Single-cell analysis of anti-BCMA CAR T cell therapy in patients with central nervous system autoimmunity
6小时前
待确认
Anti-BCMA/GPRC5D bispecific CAR T cells in patients with relapsed or refractory multiple myeloma: a single-arm, single-centre, phase 1 trial
6小时前
待确认
Long-Term Safety and Efficacy of the Fully Human CAR-T Therapy CT103A in Relapsed/Refractory Multiple Myeloma
6小时前
待确认
Ciltacabtagene autoleucel, a B-cell maturation antigen-directed chimeric antigen receptor T-cell therapy in patients with relapsed or refractory multiple myeloma (CARTITUDE-1): a phase 1b/2 open-label study
3天前
已完结
Hypogammaglobulinemia after front-line immunochemotherapy in patients with follicular lymphoma
3天前
已完结
Idecabtagene Vicleucel in Relapsed and Refractory Multiple Myeloma
3天前
已完结
Idecabtagene Vicleucel in Relapsed and Refractory Multiple Myeloma
3天前
已完结
Outcomes After Brexucabtagene Autoleucel Administered as a Standard Therapy for Adults With Relapsed/Refractory B-Cell ALL
3天前
已完结
Hypogammaglobulinemia After Chimeric Antigen Receptor (CAR) T-Cell Therapy: Characteristics, Management, and Future Directions
3天前
已完结
Digital polymerase chain reaction strategies for accurate and precise detection of vector copy number in chimeric antigen receptor T-cell products
3天前
已完结
皖公网安备34019202002308
